Download PDF
Thromb Haemost 1984; 51(01): 115-118
DOI: 10.1055/s-0038-1661035
Original Article
Schattauer GmbH Stuttgart

A Comparison of Spontaneous Platelet Aggregation in Whole Blood with Platelet Rich Plasma: Additional Evidence for the Role of ADP

A R Saniabadi
The University Department of Medicine, Royal Infirmary, Glasgow, and the Bioengineering Unit, University of Strathclyde, Glasgow, U. K.
,
G D O Lowe
The University Department of Medicine, Royal Infirmary, Glasgow, and the Bioengineering Unit, University of Strathclyde, Glasgow, U. K.
,
J C Barbenel
The University Department of Medicine, Royal Infirmary, Glasgow, and the Bioengineering Unit, University of Strathclyde, Glasgow, U. K.
,
C D Forbes
The University Department of Medicine, Royal Infirmary, Glasgow, and the Bioengineering Unit, University of Strathclyde, Glasgow, U. K.
› Author Affiliations
Further Information

Publication History

Received 04 October 1983

Accepted 09 December 1983

Publication Date:
19 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

ADP, generated from red blood cells is believed to be responsible for the spontaneous aggregation of platelets in whole blood. This notion is based mainly on the use of enzymes which remove ADP. We have studied spontaneous platelet aggregation in whole blood and autologous platelet rich plasma obtained from 12 healthy male and female volunteers. Platelet aggregation was quantitated by measuring the fall in the number of single platelets counted using a whole blood platelet counter (Ultra Flo 100). In a rotating tube model, the mean fall in the number of platelets due to spontaneous aggregation was 56% in whole blood but, only 3% in platelet rich plasma prepared from the same blood samples. Spontaneous platelet aggregation in whole blood was unaffected by apyrase grade I, but was reduced to 15% by apyrase grade II, to 38% by creatine phosphokinase/creatine phosphate and to 9% by pyruvate kinase/phosphoenolpyruvate. The results of this study provide additional evidence that ADP generated in whole blood triggers the spontaneous aggregation of platelets.

Key Words

Red blood cells - ADP - Spontaneous platelet aggregation
 

  • References

  • 1 Gaarder A, Jonsen J, Laland S, Hellem A, Owren PA. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 1961; 192: 531-532
    CrossrefPubMedGoogle Scholar
  • 2 Harrison MJ, Mitchell JR. Influence of red blood cells on platelet adhesiveness. Lancet 1966; 2: 1163-1164
    PubMedGoogle Scholar
  • 3 Born GV R, Bergquist D, Arfors KE. Evidence for inhibition of platelet activation in blood by a drug effect on erythrocytes. Nature 1976; 259: 233-235
    CrossrefPubMedGoogle Scholar
  • 4 Born GV R, Wehmeier A. Inhibition of platelet thrombus formation by chlorpromazine acting to diminish haemolysis. Nature 1979; 282: 212-213
    CrossrefPubMedGoogle Scholar
  • 5 Bergqvist D, Arfors KE. Haemostatic platelet plug formation in the isolated rabbit mesenteric preparation - an analysis of red blood cell participation. Thromb Haemostas 1980; 44: 6-8
    PubMedGoogle Scholar
  • 6 Born GV R. Fluid-mechanical and biochemical interactions in haemostasis. Br Med Bull 1977; 33: 193-197
    CrossrefPubMedGoogle Scholar
  • 7 Born GV R. Possible role for chlorpromazine in protection against myocardial infarction. Lancet 1979; 1: 822 P
    PubMedGoogle Scholar
  • 8 Day HJ, Young EB S, Helfrich MB. An evaluation of a whole- blood platelet counter. Am J Clin Pathol 1980; 73: 588-593
    CrossrefPubMedGoogle Scholar
  • 9 Guthrie DL, Lam KT, Priest CJ. The Ultra-Flo 100 platelet counter: a new approach to platelet counting. Clin Lab Haematol 1980; 2: 231-242
    CrossrefPubMedGoogle Scholar
  • 10 Lumley P, Humphrey PP A. A method for quantitating platelet aggregation and analysing drug-receptor interactions on platelets in whole blood in vitro. J Pharmacol Methods 1981; 6: 153-166
    CrossrefPubMedGoogle Scholar
  • 11 Saniabadi AR, Lowe GD O, Forbes CD, Prentice CR M, Barbenel JC. Platelet aggregation studies in whole human blood. Thromb Res 1983; 30: 625-632
    CrossrefPubMedGoogle Scholar
  • 12 Clay Adams Ultra Flo 100. Operator’s Manual. 1978
    PubMedGoogle Scholar
  • 13 Blackwell GJ, Flower RJ, Russell-Smith N, Salmon JA, Thorogood PB, Vane JR. Prostacyclin is produced in whole blood. Br J Pharmacol 1978; 64: 436 P
    PubMedGoogle Scholar
  • 14 Dyckmyn H, Proesmans W, Vermylen J. Prostacyclin production in whole blood from children: impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure. Thromb Res 1983; 30: 13-18
    CrossrefPubMedGoogle Scholar
  • 15 McPherson VJ, Zucker MB, Friedberg NM, Rifkin PL. Platelet retention in glass bead columns: Further evidence for the importance of ADP. Blood 1974; 44: 411-425
    PubMedGoogle Scholar
  • 16 Haslam RJ. Role of adenosine diphosphate in the aggregation of human-blood-platelets by thrombin and by fatty acids. Nature 1964; 202: 765-768
    CrossrefPubMedGoogle Scholar
  • 17 Vargaftig BB, Chingard M, Le Couedic JP, Benvehist J. One, two, three or more pathways for platelet aggregation. Acta Med Scand 1980; (Suppl. 642) 23-29
    PubMedGoogle Scholar
  • 18 Nunn B, Chamberlain PD. Further evidence against using ADP- removing enzyme system (CP/CPK) for demonstrating the role of secreted ADP in platelet activation. Thromb Res 1983; 30: 19-26
    CrossrefPubMedGoogle Scholar
  • 19 Hellem AJ. The adhesiveness of human blood platelets in vitro. Scand J Clin Lab Invest 1960; 12 Suppl (Suppl. 51) 1-117
    CrossrefPubMedGoogle Scholar
  • 20 Seaman P. Membrane actions of anaesthetics and tranquilizers. Pharmacol Rev 1972; 24: 583-655
    PubMedGoogle Scholar